|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:NUBPL-PSMA6 (FusionGDB2 ID:60376) |
Fusion Gene Summary for NUBPL-PSMA6 |
Fusion gene summary |
Fusion gene information | Fusion gene name: NUBPL-PSMA6 | Fusion gene ID: 60376 | Hgene | Tgene | Gene symbol | NUBPL | PSMA6 | Gene ID | 80224 | 5687 |
Gene name | nucleotide binding protein like | proteasome 20S subunit alpha 6 | |
Synonyms | C14orf127|IND1|MC1DN21|huInd1 | IOTA|PROS27|p27K | |
Cytomap | 14q12 | 14q13.2 | |
Type of gene | protein-coding | protein-coding | |
Description | iron-sulfur protein NUBPLIND1 homologiron-sulfur protein required for NADH dehydrogenase | proteasome subunit alpha type-627 kDa prosomal proteinPROS-27macropain iota chainmacropain subunit iotamulticatalytic endopeptidase complex iota chainprosomal P27K proteinproteasome (prosome, macropain) subunit, alpha type, 6proteasome iota chain | |
Modification date | 20200313 | 20200327 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000281081, ENST00000536705, ENST00000418681, | ENST00000540871, ENST00000261479, ENST00000553809, ENST00000555764, ENST00000556506, | |
Fusion gene scores | * DoF score | 10 X 8 X 6=480 | 12 X 9 X 7=756 |
# samples | 10 | 12 | |
** MAII score | log2(10/480*10)=-2.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(12/756*10)=-2.65535182861255 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: NUBPL [Title/Abstract] AND PSMA6 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | NUBPL(32068585)-PSMA6(35782087), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene breakpoints across NUBPL (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across PSMA6 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | PAAD | TCGA-2J-AABO-01A | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + |
Top |
Fusion Gene ORF analysis for NUBPL-PSMA6 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000281081 | ENST00000540871 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + |
In-frame | ENST00000281081 | ENST00000261479 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + |
In-frame | ENST00000281081 | ENST00000553809 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + |
In-frame | ENST00000281081 | ENST00000555764 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + |
In-frame | ENST00000281081 | ENST00000556506 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + |
In-frame | ENST00000536705 | ENST00000540871 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + |
In-frame | ENST00000536705 | ENST00000261479 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + |
In-frame | ENST00000536705 | ENST00000553809 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + |
In-frame | ENST00000536705 | ENST00000555764 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + |
In-frame | ENST00000536705 | ENST00000556506 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + |
intron-3CDS | ENST00000418681 | ENST00000540871 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + |
intron-3CDS | ENST00000418681 | ENST00000261479 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + |
intron-3CDS | ENST00000418681 | ENST00000553809 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + |
intron-3CDS | ENST00000418681 | ENST00000555764 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + |
intron-3CDS | ENST00000418681 | ENST00000556506 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000281081 | NUBPL | chr14 | 32068585 | + | ENST00000540871 | PSMA6 | chr14 | 35782087 | + | 920 | 427 | 45 | 758 | 237 |
ENST00000281081 | NUBPL | chr14 | 32068585 | + | ENST00000261479 | PSMA6 | chr14 | 35782087 | + | 927 | 427 | 45 | 758 | 237 |
ENST00000281081 | NUBPL | chr14 | 32068585 | + | ENST00000553809 | PSMA6 | chr14 | 35782087 | + | 799 | 427 | 45 | 431 | 128 |
ENST00000281081 | NUBPL | chr14 | 32068585 | + | ENST00000555764 | PSMA6 | chr14 | 35782087 | + | 946 | 427 | 45 | 758 | 237 |
ENST00000281081 | NUBPL | chr14 | 32068585 | + | ENST00000556506 | PSMA6 | chr14 | 35782087 | + | 777 | 427 | 45 | 629 | 194 |
ENST00000536705 | NUBPL | chr14 | 32068585 | + | ENST00000540871 | PSMA6 | chr14 | 35782087 | + | 587 | 94 | 0 | 425 | 141 |
ENST00000536705 | NUBPL | chr14 | 32068585 | + | ENST00000261479 | PSMA6 | chr14 | 35782087 | + | 594 | 94 | 0 | 425 | 141 |
ENST00000536705 | NUBPL | chr14 | 32068585 | + | ENST00000553809 | PSMA6 | chr14 | 35782087 | + | 466 | 94 | 95 | 424 | 109 |
ENST00000536705 | NUBPL | chr14 | 32068585 | + | ENST00000555764 | PSMA6 | chr14 | 35782087 | + | 613 | 94 | 0 | 425 | 141 |
ENST00000536705 | NUBPL | chr14 | 32068585 | + | ENST00000556506 | PSMA6 | chr14 | 35782087 | + | 444 | 94 | 0 | 296 | 98 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000281081 | ENST00000540871 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + | 0.001049953 | 0.99895006 |
ENST00000281081 | ENST00000261479 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + | 0.001003773 | 0.9989962 |
ENST00000281081 | ENST00000553809 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + | 0.034348648 | 0.9656514 |
ENST00000281081 | ENST00000555764 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + | 0.000934029 | 0.99906594 |
ENST00000281081 | ENST00000556506 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + | 0.002880891 | 0.9971192 |
ENST00000536705 | ENST00000540871 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + | 0.003356307 | 0.99664366 |
ENST00000536705 | ENST00000261479 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + | 0.003611709 | 0.9963883 |
ENST00000536705 | ENST00000553809 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + | 0.020623596 | 0.97937644 |
ENST00000536705 | ENST00000555764 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + | 0.003299485 | 0.99670047 |
ENST00000536705 | ENST00000556506 | NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782087 | + | 0.024253853 | 0.97574615 |
Top |
Fusion Genomic Features for NUBPL-PSMA6 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782086 | + | 5.79E-06 | 0.99999416 |
NUBPL | chr14 | 32068585 | + | PSMA6 | chr14 | 35782086 | + | 5.79E-06 | 0.99999416 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for NUBPL-PSMA6 |
Go to FGviewer for the breakpoints of chr14:32068585-chr14:35782087 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | NUBPL | chr14:32068585 | chr14:35782087 | ENST00000281081 | + | 4 | 11 | 75_82 | 127.33333333333333 | 320.0 | Nucleotide binding | ATP |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for NUBPL-PSMA6 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000281081_ENST00000540871_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(transcript)=920nt_BP=427nt ACCCGCGACAGTTTCCCAGCAGGGCTCACAGCAGCGTTCCGCGTCATGGGGATTTGGCAGCGTCTGCTGCTTTTTGGTGGGGTGTCGCTC CGGGCTGGTGGCGGGGCCACTGCCCCGCTTGGGGGAAGCCGAGCGATGGTTTGTGGGCGCCAGTTGTCTGGCGCCGGGAGTGAGACCCTA AAACAAAGAAGAACACAAATCATGTCCCGAGGACTTCCAAAGCAGAAACCGATAGAAGGTGTTAAACAAGTTATAGTTGTGGCTTCTGGA AAGGGTGGAGTCGGAAAATCTACTACAGCAGTGAATCTTGCACTTGCACTAGCAGCGAACGATTCGTCCAAGGCCATTGGTTTGCTAGAT GTGGATGTGTATGGACCTTCAGTTCCAAAGATGATGAATCTGAAAGGAAATCCGGAATTATCACAGAGTATGATTTTAATTGGTATAGAT GAAGAGCAAGGCCCTCAGGTATATAAGTGTGATCCTGCAGGTTACTACTGTGGGTTTAAAGCCACTGCAGCGGGAGTTAAACAAACTGAG TCAACCAGCTTCCTTGAAAAAAAAGTGAAGAAGAAATTTGATTGGACATTTGAACAGACAGTGGAAACTGCAATTACATGCCTGTCTACT GTTCTATCAATTGATTTCAAACCTTCAGAAATAGAAGTTGGAGTAGTGACAGTTGAAAATCCTAAATTCAGGATTCTTACAGAAGCAGAG ATTGATGCTCACCTTGTTGCTCTAGCAGAGAGAGACTAAACATTGTCGTTAGTTTACCAGATCCGTGATGCCACTTACCTGTGTGTTTGG TAACAACAAACCAACATCATGGAGGTCCCTGGATTGAAAAAGGAGCCTCTCCCACTCCTCCTACCACCGAAGTGGTTAGGACTCTATATA >In-frame_ENST00000281081_ENST00000540871_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(amino acids)=237AA_start in transcript=45_stop in transcript=758 MGIWQRLLLFGGVSLRAGGGATAPLGGSRAMVCGRQLSGAGSETLKQRRTQIMSRGLPKQKPIEGVKQVIVVASGKGGVGKSTTAVNLAL ALAANDSSKAIGLLDVDVYGPSVPKMMNLKGNPELSQSMILIGIDEEQGPQVYKCDPAGYYCGFKATAAGVKQTESTSFLEKKVKKKFDW -------------------------------------------------------------- >In-frame_ENST00000281081_ENST00000261479_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(transcript)=927nt_BP=427nt ACCCGCGACAGTTTCCCAGCAGGGCTCACAGCAGCGTTCCGCGTCATGGGGATTTGGCAGCGTCTGCTGCTTTTTGGTGGGGTGTCGCTC CGGGCTGGTGGCGGGGCCACTGCCCCGCTTGGGGGAAGCCGAGCGATGGTTTGTGGGCGCCAGTTGTCTGGCGCCGGGAGTGAGACCCTA AAACAAAGAAGAACACAAATCATGTCCCGAGGACTTCCAAAGCAGAAACCGATAGAAGGTGTTAAACAAGTTATAGTTGTGGCTTCTGGA AAGGGTGGAGTCGGAAAATCTACTACAGCAGTGAATCTTGCACTTGCACTAGCAGCGAACGATTCGTCCAAGGCCATTGGTTTGCTAGAT GTGGATGTGTATGGACCTTCAGTTCCAAAGATGATGAATCTGAAAGGAAATCCGGAATTATCACAGAGTATGATTTTAATTGGTATAGAT GAAGAGCAAGGCCCTCAGGTATATAAGTGTGATCCTGCAGGTTACTACTGTGGGTTTAAAGCCACTGCAGCGGGAGTTAAACAAACTGAG TCAACCAGCTTCCTTGAAAAAAAAGTGAAGAAGAAATTTGATTGGACATTTGAACAGACAGTGGAAACTGCAATTACATGCCTGTCTACT GTTCTATCAATTGATTTCAAACCTTCAGAAATAGAAGTTGGAGTAGTGACAGTTGAAAATCCTAAATTCAGGATTCTTACAGAAGCAGAG ATTGATGCTCACCTTGTTGCTCTAGCAGAGAGAGACTAAACATTGTCGTTAGTTTACCAGATCCGTGATGCCACTTACCTGTGTGTTTGG TAACAACAAACCAACATCATGGAGGTCCCTGGATTGAAAAAGGAGCCTCTCCCACTCCTCCTACCACCGAAGTGGTTAGGACTCTATATA >In-frame_ENST00000281081_ENST00000261479_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(amino acids)=237AA_start in transcript=45_stop in transcript=758 MGIWQRLLLFGGVSLRAGGGATAPLGGSRAMVCGRQLSGAGSETLKQRRTQIMSRGLPKQKPIEGVKQVIVVASGKGGVGKSTTAVNLAL ALAANDSSKAIGLLDVDVYGPSVPKMMNLKGNPELSQSMILIGIDEEQGPQVYKCDPAGYYCGFKATAAGVKQTESTSFLEKKVKKKFDW -------------------------------------------------------------- >In-frame_ENST00000281081_ENST00000553809_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(transcript)=799nt_BP=427nt ACCCGCGACAGTTTCCCAGCAGGGCTCACAGCAGCGTTCCGCGTCATGGGGATTTGGCAGCGTCTGCTGCTTTTTGGTGGGGTGTCGCTC CGGGCTGGTGGCGGGGCCACTGCCCCGCTTGGGGGAAGCCGAGCGATGGTTTGTGGGCGCCAGTTGTCTGGCGCCGGGAGTGAGACCCTA AAACAAAGAAGAACACAAATCATGTCCCGAGGACTTCCAAAGCAGAAACCGATAGAAGGTGTTAAACAAGTTATAGTTGTGGCTTCTGGA AAGGGTGGAGTCGGAAAATCTACTACAGCAGTGAATCTTGCACTTGCACTAGCAGCGAACGATTCGTCCAAGGCCATTGGTTTGCTAGAT GTGGATGTGTATGGACCTTCAGTTCCAAAGATGATGAATCTGAAAGGAAATCCGGAATTATCACAGATATGATTTTAATTGGTATAGATG AAGAGCAAGGCCCTCAGGTATATAAGTGTGATCCTGCAGGTTACTACTGTGGGTTTAAAGCCACTGCAGCGGGAGTTAAACAAACTGAGT CAACCAGCTTCCTTGAAAAAAAAGTGAAGAAGAAATTTGATTGGACATTTGAACAGACAGTGGAAACTGCAATTACATGCCTGTCTACTG TTCTATCAATTGATTTCAAACCTTCAGAAATAGAAGTTGGAGTAGTGACAGTTGAAAATCCTAAATTCAGGATTCTTACAGAAGCAGAGA >In-frame_ENST00000281081_ENST00000553809_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(amino acids)=128AA_start in transcript=45_stop in transcript=431 MGIWQRLLLFGGVSLRAGGGATAPLGGSRAMVCGRQLSGAGSETLKQRRTQIMSRGLPKQKPIEGVKQVIVVASGKGGVGKSTTAVNLAL -------------------------------------------------------------- >In-frame_ENST00000281081_ENST00000555764_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(transcript)=946nt_BP=427nt ACCCGCGACAGTTTCCCAGCAGGGCTCACAGCAGCGTTCCGCGTCATGGGGATTTGGCAGCGTCTGCTGCTTTTTGGTGGGGTGTCGCTC CGGGCTGGTGGCGGGGCCACTGCCCCGCTTGGGGGAAGCCGAGCGATGGTTTGTGGGCGCCAGTTGTCTGGCGCCGGGAGTGAGACCCTA AAACAAAGAAGAACACAAATCATGTCCCGAGGACTTCCAAAGCAGAAACCGATAGAAGGTGTTAAACAAGTTATAGTTGTGGCTTCTGGA AAGGGTGGAGTCGGAAAATCTACTACAGCAGTGAATCTTGCACTTGCACTAGCAGCGAACGATTCGTCCAAGGCCATTGGTTTGCTAGAT GTGGATGTGTATGGACCTTCAGTTCCAAAGATGATGAATCTGAAAGGAAATCCGGAATTATCACAGAGTATGATTTTAATTGGTATAGAT GAAGAGCAAGGCCCTCAGGTATATAAGTGTGATCCTGCAGGTTACTACTGTGGGTTTAAAGCCACTGCAGCGGGAGTTAAACAAACTGAG TCAACCAGCTTCCTTGAAAAAAAAGTGAAGAAGAAATTTGATTGGACATTTGAACAGACAGTGGAAACTGCAATTACATGCCTGTCTACT GTTCTATCAATTGATTTCAAACCTTCAGAAATAGAAGTTGGAGTAGTGACAGTTGAAAATCCTAAATTCAGGATTCTTACAGAAGCAGAG ATTGATGCTCACCTTGTTGCTCTAGCAGAGAGAGACTAAACATTGTCGTTAGTTTACCAGATCCGTGATGCCACTTACCTGTGTGTTTGG TAACAACAAACCAACATCATGGAGGTCCCTGGATTGAAAAAGGAGCCTCTCCCACTCCTCCTACCACCGAAGTGGTTAGGACTCTATATA >In-frame_ENST00000281081_ENST00000555764_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(amino acids)=237AA_start in transcript=45_stop in transcript=758 MGIWQRLLLFGGVSLRAGGGATAPLGGSRAMVCGRQLSGAGSETLKQRRTQIMSRGLPKQKPIEGVKQVIVVASGKGGVGKSTTAVNLAL ALAANDSSKAIGLLDVDVYGPSVPKMMNLKGNPELSQSMILIGIDEEQGPQVYKCDPAGYYCGFKATAAGVKQTESTSFLEKKVKKKFDW -------------------------------------------------------------- >In-frame_ENST00000281081_ENST00000556506_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(transcript)=777nt_BP=427nt ACCCGCGACAGTTTCCCAGCAGGGCTCACAGCAGCGTTCCGCGTCATGGGGATTTGGCAGCGTCTGCTGCTTTTTGGTGGGGTGTCGCTC CGGGCTGGTGGCGGGGCCACTGCCCCGCTTGGGGGAAGCCGAGCGATGGTTTGTGGGCGCCAGTTGTCTGGCGCCGGGAGTGAGACCCTA AAACAAAGAAGAACACAAATCATGTCCCGAGGACTTCCAAAGCAGAAACCGATAGAAGGTGTTAAACAAGTTATAGTTGTGGCTTCTGGA AAGGGTGGAGTCGGAAAATCTACTACAGCAGTGAATCTTGCACTTGCACTAGCAGCGAACGATTCGTCCAAGGCCATTGGTTTGCTAGAT GTGGATGTGTATGGACCTTCAGTTCCAAAGATGATGAATCTGAAAGGAAATCCGGAATTATCACAGAGTATGATTTTAATTGGTATAGAT GAAGAGCAAGGCCCTCAGGTATATAAGTGTGATCCTGCAGGTTACTACTGTGGGTTTAAAGCCACTGCAGCGGGAGTTAAACAAACTGAG TCAACCAGCTTCCTTGAAAAAAAAGTGAAGAAGAAATTTGATTGGACATTTGAACAGACAGTGGAAGATTCTTACAGAAGCAGAGATTGA TGCTCACCTTGTTGCTCTAGCAGAGAGAGACTAAACATTGTCGTTAGTTTACCAGATCCGTGATGCCACTTACCTGTGTGTTTGGTAACA >In-frame_ENST00000281081_ENST00000556506_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(amino acids)=194AA_start in transcript=45_stop in transcript=629 MGIWQRLLLFGGVSLRAGGGATAPLGGSRAMVCGRQLSGAGSETLKQRRTQIMSRGLPKQKPIEGVKQVIVVASGKGGVGKSTTAVNLAL ALAANDSSKAIGLLDVDVYGPSVPKMMNLKGNPELSQSMILIGIDEEQGPQVYKCDPAGYYCGFKATAAGVKQTESTSFLEKKVKKKFDW -------------------------------------------------------------- >In-frame_ENST00000536705_ENST00000540871_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(transcript)=587nt_BP=94nt ATGTCCAAGGCCATTGGTTTGCTAGATGTGGATGTGTATGGACCTTCAGTTCCAAAGATGATGAATCTGAAAGGAAATCCGGAATTATCA CAGAGTATGATTTTAATTGGTATAGATGAAGAGCAAGGCCCTCAGGTATATAAGTGTGATCCTGCAGGTTACTACTGTGGGTTTAAAGCC ACTGCAGCGGGAGTTAAACAAACTGAGTCAACCAGCTTCCTTGAAAAAAAAGTGAAGAAGAAATTTGATTGGACATTTGAACAGACAGTG GAAACTGCAATTACATGCCTGTCTACTGTTCTATCAATTGATTTCAAACCTTCAGAAATAGAAGTTGGAGTAGTGACAGTTGAAAATCCT AAATTCAGGATTCTTACAGAAGCAGAGATTGATGCTCACCTTGTTGCTCTAGCAGAGAGAGACTAAACATTGTCGTTAGTTTACCAGATC CGTGATGCCACTTACCTGTGTGTTTGGTAACAACAAACCAACATCATGGAGGTCCCTGGATTGAAAAAGGAGCCTCTCCCACTCCTCCTA >In-frame_ENST00000536705_ENST00000540871_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(amino acids)=141AA_start in transcript=0_stop in transcript=425 MSKAIGLLDVDVYGPSVPKMMNLKGNPELSQSMILIGIDEEQGPQVYKCDPAGYYCGFKATAAGVKQTESTSFLEKKVKKKFDWTFEQTV -------------------------------------------------------------- >In-frame_ENST00000536705_ENST00000261479_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(transcript)=594nt_BP=94nt ATGTCCAAGGCCATTGGTTTGCTAGATGTGGATGTGTATGGACCTTCAGTTCCAAAGATGATGAATCTGAAAGGAAATCCGGAATTATCA CAGAGTATGATTTTAATTGGTATAGATGAAGAGCAAGGCCCTCAGGTATATAAGTGTGATCCTGCAGGTTACTACTGTGGGTTTAAAGCC ACTGCAGCGGGAGTTAAACAAACTGAGTCAACCAGCTTCCTTGAAAAAAAAGTGAAGAAGAAATTTGATTGGACATTTGAACAGACAGTG GAAACTGCAATTACATGCCTGTCTACTGTTCTATCAATTGATTTCAAACCTTCAGAAATAGAAGTTGGAGTAGTGACAGTTGAAAATCCT AAATTCAGGATTCTTACAGAAGCAGAGATTGATGCTCACCTTGTTGCTCTAGCAGAGAGAGACTAAACATTGTCGTTAGTTTACCAGATC CGTGATGCCACTTACCTGTGTGTTTGGTAACAACAAACCAACATCATGGAGGTCCCTGGATTGAAAAAGGAGCCTCTCCCACTCCTCCTA >In-frame_ENST00000536705_ENST00000261479_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(amino acids)=141AA_start in transcript=0_stop in transcript=425 MSKAIGLLDVDVYGPSVPKMMNLKGNPELSQSMILIGIDEEQGPQVYKCDPAGYYCGFKATAAGVKQTESTSFLEKKVKKKFDWTFEQTV -------------------------------------------------------------- >In-frame_ENST00000536705_ENST00000553809_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(transcript)=466nt_BP=94nt ATGTCCAAGGCCATTGGTTTGCTAGATGTGGATGTGTATGGACCTTCAGTTCCAAAGATGATGAATCTGAAAGGAAATCCGGAATTATCA CAGATATGATTTTAATTGGTATAGATGAAGAGCAAGGCCCTCAGGTATATAAGTGTGATCCTGCAGGTTACTACTGTGGGTTTAAAGCCA CTGCAGCGGGAGTTAAACAAACTGAGTCAACCAGCTTCCTTGAAAAAAAAGTGAAGAAGAAATTTGATTGGACATTTGAACAGACAGTGG AAACTGCAATTACATGCCTGTCTACTGTTCTATCAATTGATTTCAAACCTTCAGAAATAGAAGTTGGAGTAGTGACAGTTGAAAATCCTA AATTCAGGATTCTTACAGAAGCAGAGATTGATGCTCACCTTGTTGCTCTAGCAGAGAGAGACTAAACATTGTCGTTAGTTTACCAGATCC >In-frame_ENST00000536705_ENST00000553809_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(amino acids)=109AA_start in transcript=95_stop in transcript=424 MILIGIDEEQGPQVYKCDPAGYYCGFKATAAGVKQTESTSFLEKKVKKKFDWTFEQTVETAITCLSTVLSIDFKPSEIEVGVVTVENPKF -------------------------------------------------------------- >In-frame_ENST00000536705_ENST00000555764_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(transcript)=613nt_BP=94nt ATGTCCAAGGCCATTGGTTTGCTAGATGTGGATGTGTATGGACCTTCAGTTCCAAAGATGATGAATCTGAAAGGAAATCCGGAATTATCA CAGAGTATGATTTTAATTGGTATAGATGAAGAGCAAGGCCCTCAGGTATATAAGTGTGATCCTGCAGGTTACTACTGTGGGTTTAAAGCC ACTGCAGCGGGAGTTAAACAAACTGAGTCAACCAGCTTCCTTGAAAAAAAAGTGAAGAAGAAATTTGATTGGACATTTGAACAGACAGTG GAAACTGCAATTACATGCCTGTCTACTGTTCTATCAATTGATTTCAAACCTTCAGAAATAGAAGTTGGAGTAGTGACAGTTGAAAATCCT AAATTCAGGATTCTTACAGAAGCAGAGATTGATGCTCACCTTGTTGCTCTAGCAGAGAGAGACTAAACATTGTCGTTAGTTTACCAGATC CGTGATGCCACTTACCTGTGTGTTTGGTAACAACAAACCAACATCATGGAGGTCCCTGGATTGAAAAAGGAGCCTCTCCCACTCCTCCTA >In-frame_ENST00000536705_ENST00000555764_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(amino acids)=141AA_start in transcript=0_stop in transcript=425 MSKAIGLLDVDVYGPSVPKMMNLKGNPELSQSMILIGIDEEQGPQVYKCDPAGYYCGFKATAAGVKQTESTSFLEKKVKKKFDWTFEQTV -------------------------------------------------------------- >In-frame_ENST00000536705_ENST00000556506_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(transcript)=444nt_BP=94nt ATGTCCAAGGCCATTGGTTTGCTAGATGTGGATGTGTATGGACCTTCAGTTCCAAAGATGATGAATCTGAAAGGAAATCCGGAATTATCA CAGAGTATGATTTTAATTGGTATAGATGAAGAGCAAGGCCCTCAGGTATATAAGTGTGATCCTGCAGGTTACTACTGTGGGTTTAAAGCC ACTGCAGCGGGAGTTAAACAAACTGAGTCAACCAGCTTCCTTGAAAAAAAAGTGAAGAAGAAATTTGATTGGACATTTGAACAGACAGTG GAAGATTCTTACAGAAGCAGAGATTGATGCTCACCTTGTTGCTCTAGCAGAGAGAGACTAAACATTGTCGTTAGTTTACCAGATCCGTGA >In-frame_ENST00000536705_ENST00000556506_TCGA-2J-AABO-01A_NUBPL_chr14_32068585_+_PSMA6_chr14_35782087_length(amino acids)=98AA_start in transcript=0_stop in transcript=296 MSKAIGLLDVDVYGPSVPKMMNLKGNPELSQSMILIGIDEEQGPQVYKCDPAGYYCGFKATAAGVKQTESTSFLEKKVKKKFDWTFEQTV -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for NUBPL-PSMA6 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for NUBPL-PSMA6 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for NUBPL-PSMA6 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | NUBPL | C1838979 | MITOCHONDRIAL COMPLEX I DEFICIENCY | 4 | GENOMICS_ENGLAND;ORPHANET |
Hgene | NUBPL | C0751651 | Mitochondrial Diseases | 2 | CTD_human;GENOMICS_ENGLAND |
Hgene | NUBPL | C4748792 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21 | 2 | GENOMICS_ENGLAND;UNIPROT |
Hgene | NUBPL | C0949855 | Electron Transport Chain Deficiencies, Mitochondrial | 1 | CTD_human |
Hgene | NUBPL | C0949856 | Oxidative Phosphorylation Deficiencies | 1 | CTD_human |
Hgene | NUBPL | C0949857 | Mitochondrial Respiratory Chain Deficiencies | 1 | CTD_human |
Tgene | PSMA6 | C0019693 | HIV Infections | 1 | CTD_human |
Tgene | PSMA6 | C0027051 | Myocardial Infarction | 1 | CTD_human |
Tgene | PSMA6 | C4505456 | HIV Coinfection | 1 | CTD_human |